In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...

A new review finds that eating kimchi—the iconic Korean fermented dish—may help lower blood sugar, triglycerides, and blood ...

Canned foods are convenient and good for you, too. For heart health, don’t ignore these fiber-rich and omega-3-packed pantry staples. “Shop the perimeter of the grocery store” is a well-intentioned ...

Omega-3s may reduce the risk of high blood pressure, but fish oil may be more effective in people with high blood pressure or high triglycerides. Learn why.

Celebrating Scientific Advancement Amarin applauds the groundbreaking work addressing sHTG and rare genetic disorders such as familial chylomicronemia syndrome (FCS). These advances help drive patient ...

PHILADELPHIA, PA—Therapies using RNA interference (RNAi) to target genes that encode proteins involved in lipid and lipoprotein metabolism—specifically apolipoprotein C-III (APOC3) and ...

High triglycerides, widely known as an enemy of the aging heart, may not be as threatening to older adults' brains, new research suggests. The study, of over 80,000 older adults, found those with ...

Prescription omega-3 fatty acids are an "effective and safe option" to cut down triglycerides, according to a science advisory released by the American Heart Association (AHA). However, ...

Evinacumab (Evkeeza; Regeneron) can substantially reduce fasting triglyceride levels in patients with severe hypertriglyceridemia, although to a variable degree and not among those with the rare ...

Please provide your email address to receive an email when new articles are posted on . Plozasiran lowered triglycerides and reduced risk for pancreatitis vs. placebo in patients with chylomicronemia.

The evidence for elevated triglycerides, as a cardiac risk factor, is nowhere near as well understood as the risk from high LDL and low HDL cholesterol. However, the growing body of epidemiologic ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLO™ (plozasiran), a small interfering RNA (siRNA) medicine, ...